|
|
 |
|
Viewing report
|
|
|
|
Bioanalysis in Cancer Research
Future Science Ltd, May 2010, Pages: 118
Statistics from the World Health Organization show cancer to be a leading cause of death worldwide, with 7.4 million deaths (~13% of all deaths worldwide) attributed to cancer in 2004. This rate is predicted to continue growing, with an estimated 12 million cancer deaths predicted for 2030. Tumors arise from a single normal cell and are caused by interactions between genetic factors and exposure to any of the following: physical (e.g. UV or radiation), chemical (e.g. asbestos or tobacco) and biological (e.g. hepatitis B or Human Papilloma Virus) carcinogens.
Many cancer deaths could be prevented by avoiding risk factors, for example by stopping smoking or losing weight. Survival outcomes can be significantly improved by early diagnosis, appropriate disease monitoring and disease management.
Bioanalysis has a pivotal role in cancer diagnosis and prognosis, determining the appropriate therapy and, subsequently, monitoring the effectiveness of the therapy. Important topics such as quantification of diagnostic and prognostic biomarkers, genomics for determining the appropriate therapy for particular patients and the role of therapeutic drug monitoring in chemotherapy management are discussed by international experts in this special focus issue of Bioanalysis.
Product samples
A sample for this product is available. Please Login/Register to download this sample.
Customers who bought this item also bought
Biomarkers - Technologies, Markets and Companies
Nanobiotechnology Applications, Markets and Companies
RNAi - Technologies, Markets and Companies
Cytogenetics - Technologies, Markets and Companies
Gene Therapy - Technologies, Markets and Companies
Proteomics - Technologies, Markets and Companies
Cell Therapy - Technologies, Markets and Companies
Animal Biotechnology - Technologies, Markets and Companies
Hot Topics: Impact of Biomarkers in Alzheimer's Disease - Dx-Rx collaboration paves the way for personalized medicine
Antiviral Therapeutics - Technologies, Markets and Companies
|
|
|
|
